In order to early identify and predict RTLI after IMRT in patients with NPC, we developed and validated a radiomics model based on pretreatment MRI of temporal lobe. The radiomics model demonstrated excellent predictive performance in the validation set (AUC, 0.93; sensitivity, 87%; specificity, 97%). The clinical-radiomics nomogram outperformed clinical nomogram, and showed excellent predictive performance of RTLI in patients within different clinical-pathologic subgroups. These findings suggest that the identified radiomics signature has the potential as a biomarker for risk stratification in RTLI, which may potentially improve the quality of life and prognosis in NPC patients.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords